Skip to main content
Have a personal or library account? Click to login
Evaluation of muscle strength and renal function in survivors of severe COVID-19: A 12-month follow-up study Cover

Evaluation of muscle strength and renal function in survivors of severe COVID-19: A 12-month follow-up study

Open Access
|Apr 2026

References

  1. Centers for Disease Control and Prevention. People with Certain Medical Conditions and COVID-19 Risk Factors [Internet]. Atlanta (GA): CDC; 2025 [cited 2025 Jan 4]. Available from: https://www.cdc.gov/covid/risk-factors/index.html
  2. Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:.
  3. Raschke RA, et al. Discriminant accuracy of the SOFA score for determining the probable mortality of patients with COVID-19 pneumonia requiring mechanical ventilation. JAMA. 2021;325(14):1469–1470.
  4. Brazil. Ministry of Health. Coronavirus Panel: COVID-19 data in Brazil [Internet]. Brasília (DF): Ministry of Health; 2025 [cited 2025 Feb 26]. Available from: https://covid.saude.gov.br/
  5. Grasselli G, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574–1581.
  6. Gabarre P, et al. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46(7):1339–1348.
  7. Chakraborty I, Maity P. COVID-19 outbreak: migration, effects on society, global environment and prevention. Sci Total Environ. 2020;728:138882.
  8. Veras FP. Neutrophil extracellular traps (NETs): importance in pathogenesis and potential therapeutic target during COVID-19 [thesis]. Ribeirão Preto (SP): University of São Paulo; 2022.
  9. Xia H, Lazartigues E. Angiotensin-converting enzyme 2: central regulator for cardiovascular function. Curr Hypertens Rep. 2010;12(3):170–175.
  10. Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–615.
  11. Bowe B, et al. Kidney outcomes in long COVID. J Am Soc Nephrol. 2021;32(11):2851–2862.
  12. Yang D, et al. Physical function in kidney transplantation: current knowledge and future directions. Curr Transplant Rep. 2020;7(2):46–55.
  13. Gutiérrez-Chamorro L, et al. SARS-CoV-2 infection modulates ACE2 function and subsequent inflammatory responses in swabs and plasma of COVID-19 patients. Viruses. 2021;13(9):1715.
  14. Hirsch JS, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209–218.
  15. Andrade RO. The effects of Covid-19: months after overcoming the acute phase of the disease, some patients still have persistent complications in the lungs, heart or brain. Rev Pesquisa FAPESP [Internet]. 2020 Sep;(295). Available from: https://revistapesquisa.fapesp.br/os-efeitos-da-covid-19/
  16. Ronco C, Reis T, Husain-Syed F. Management of acute kidney injury in patients with COVID-19. Lancet Respir Med. 2020;8(7):738–742.
  17. Su H, et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 2020;98(1):219–227.
  18. McWilliams D, et al. Rehabilitation levels in COVID-19 patients admitted to intensive care requiring invasive ventilation: an observational study. Ann Am Thorac Soc. 2020 Sep;.
  19. Nelke C, et al. Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine. 2019;49:381–388.
  20. Ramírez-Vélez R, et al. Reduced muscle strength in patients with long COVID-19 syndrome is mediated by limb muscle mass. J Appl Physiol. 2023;134(1):50–58.
  21. Pecly IMD, et al. A review of COVID-19 and acute kidney injury: from pathophysiology to clinical results. J Bras Nefrol. 2021;43(4):551–571.
  22. Evans RA, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021 Oct;.
  23. World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases [Internet]. Geneva: WHO; 2020 [cited 2025 Feb 26]. Available from: https://www.who.int/publications/i/item/10665-331501
  24. World Health Organization. Laboratory testing for coronavirus disease 2019 (COVID-19) in suspected human cases: interim guidance, 2 March 2020 [Internet]. Geneva: WHO; 2020 [cited 2025 Mar 9]. Available from: https://pesquisa.bvsalud.org/portal/resource/pt/who-331329
  25. Levey AS, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
  26. Hlatky MA, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64(10):651–654.
  27. Scott J, Huskisson EC. Graphic representation of pain. Pain. 1976;2(2):175–184.
  28. Aquino ALN, Silva ROE. Evaluation of the quality of life of coffee growers in Poço Fundo-MG with the SF-36 instrument during the COVID-19 pandemic. Research, Society and Development. 2021;10(16):e40101623484.
  29. Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14(8):531–532.
  30. Kirk B, et al. An executive summary on the global conceptual definition of sarcopenia. 2024;36(1):.
  31. Pagotto V, et al. Calf circumference: clinical validation for evaluation of muscle mass in the elderly. Rev Bras Enferm. 2018;71(2):322–328.
  32. Piquione FS, et al. Evaluation of peripheral muscle strength of patients hospitalized with respiratory diseases submitted to early mobilization. Research, Society and Development. 2021;10(9):e27310918045.
  33. Marincolo JCS. Indicators of frailty and time spent in activities in the elderly: data from FIBRA Campinas [Master’s Thesis]. Campinas (SP): State University of Campinas, Faculty of Medical Sciences; 2011 [cited 2025 Mar 9]. Available from: https://hdl.handle.net/20.500.12733/1614504
  34. Lombardi R, et al. Acute kidney injury in Latin America: a view on renal replacement therapy resources. Nephrol Dial Transplant. 2014;29(7):1369–1376.
  35. Hirsch JS, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209–218.
  36. Smith BH, Belton JL. Patient engagement in pain research: no gain without the people in pain. Pain. 2024;165(5):961–962.
  37. Evans DW, et al. Where is the pain? Spatial patterns of pain co-occurrence in a population-based study of 4833 pain drawings incorporating network analysis. Pain. 2025 Feb;.
  38. Nydahl P, et al. Safety of patient mobilization and rehabilitation in the intensive care unit: systematic review with meta-analysis. Ann Am Thorac Soc. 2017;14(5):766–777.
  39. Yin Y, et al. Health consequences among COVID-19 convalescent patients 30 months post-infection in China. Zoonoses. 2024;4(1):999.
  40. Toledano JM, et al. Antioxidant and immune-related implications of minerals in COVID-19: a possibility for disease prevention and management. Antioxidants (Basel). 2023;12(5):1104.
  41. Huang L, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747–758.
  42. De Blasio F, et al. Sarcopenia in post-acute COVID-19 patients: evidence from a multicenter study. J Clin Med. 2021;10(15):3402.
DOI: https://doi.org/10.62838/jccm-2026-0004 | Journal eISSN: 2393-1817 | Journal ISSN: 2393-1809
Language: English
Page range: 167 - 175
Submitted on: Aug 17, 2025
Accepted on: Jan 28, 2026
Published on: Apr 30, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Roberto Marco, Sayane Marlla Silva Leite Montenegro, Daniela Cassula, Tayline Gabriel, Alessandra Lima da Silva Martins, Rosani Teresa de Siqueira e Silva, Rosilene Motta Elias, Maria Aparecida Dalboni, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.